GlobeNewsWire · CMPGY · October 24, 2026

Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026

Get the app for more

Explore stock news, insights and company research.